132 Submission of ppt via E-Vartalap Sugam Portal 2023-Dec-19 298 KB
F. No. 12-01/2023-DC(SEC) Directorate General of Health Services Central Drugs Standard Control Organization (Expert Committee Coordination Division)
FDA Bhawan, New Delhi Dated: 19" December,2023
NOTICE
As per the procedure for evaluation of applications by Subject Expert Committee, the applicants make presentation before the committee. However, it has been observed that some of the applicants submit the copy of presentation via emails etc. on the day of meeting. In order to streamline the process of submission of presentation copy for SEC meeting, it has been decided that the copy of presentation must be submitted through e-vartalap (Sugam Portal) only to concerned division well in advance, after receipt of the invitation letter from CDSCO.
This is for compliance with immediate effect.
a Anhit Sharma Yyv Deputy Drugs Controller (India)
To All Stakeholders & CDSCO website.
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis has been generated for this document yet.